40 results
10-K
2023 FY
EX-10.2
AXSM
Axsome Therapeutics Inc
Annual report
23 Feb 24
8:10am
8-K
EX-10.1
AXSM
Axsome Therapeutics Inc
8 Jun 23
Departure of Directors or Certain Officers
5:02pm
8-K
EX-10.1
dg50utw1e
13 Jan 20
Agreement accelerates ongoing clinical development of AXS-12 (reboxetine) in narcolepsy
8:39am